Robert Hershberg, Director at Adaptive Biotechnologies Corp (ADPT), sold 2,000 shares at $44.56 ($89K) on 2021-03-08, disclosed to the SEC on 2021-03-10.
Open-market sale of $89k ADPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADPT | SELL | 2025-12-12 | $367K | — | Filing → |
| ADPT | SELL | 2025-03-12 | $402K | — | Filing → |
| HLVX | SELL | 2025-02-12 | $49K | — | Filing → |